In patients with AD, increased concentrations of NfL in plasma or serum are associated with volume loss on structural MRI, particularly in the brain regions typically affected by AD; glucose hypometabolism on FDG-PET; and loss of white matter integrity on diffusion tensor imaging [30]. Here, NEFL is linked to Alzheimer disease.